Lantern Pharma Inc. (LTRN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lantern Pharma Inc.

    NASDAQ: LTRN · Real-Time Price · USD
    4.11
    0.09 (2.24%)
    At close: Oct 03, 2025, 3:59 PM
    4.10
    -0.19%
    After-hours: Oct 03, 2025, 06:37 PM EDT

    Lantern Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.51M 21.94M 37.2M 51.52M
    Short-Term Investments
    		 16.5M 19.36M 17.99M 19.2M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 36.74K 25.87K 17.89K 1.02M
    Receivables
    		 97K 860K 592K 181K
    Inventory
    		 n/a n/a n/a -181K
    Other Current Assets
    		 1.14M 745.65K -50.82K n/a
    Total Current Assets
    		 25.25M 43.34M 58.72M 72.72M
    Property-Plant & Equipment
    		 287.43K 280.42K 95.69K 216.19K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 324.16K 306.29K 113.58K 1.23M
    Total Assets
    		 25.57M 43.65M 58.84M 73.95M
    Account Payables
    		 4.14M 942.21K 932.41K 681.11K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 52.89K 152.06K
    Other Current Liabilities
    		 4.33B 1.56M 1.76M 1.34M
    Total Current Liabilities
    		 4.33B 2.68M 2.8M 2.33M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 52.79M n/a n/a n/a
    Total Long-Term Liabilities
    		 52.84M 61.5K n/a 52.89K
    Total Liabilities
    		 4.38M 2.74M 2.8M 2.38M
    Total Debt
    		 243.66K 234.47K 52.89K 204.95K
    Book Value
    		 21.19M 40.91M 56.04M 71.57M
    Book Value Per Share
    		 1.97 3.77 5.16 6.56
    Common Stock
    		 1.08K 1.07K 1.09K 1.11K
    Retained Earnings
    		 -76.03B -55.24M -39.28M -25.02M
    Comprehensive Income
    		 153.99K -107.46K -371.39K -92.69K
    Shareholders Equity
    		 21.19M 40.91M 56.04M 71.57M
    Total Investments
    		 16.5M 19.36M 17.99M 19.2M

    Add to Watchlist